Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 316 AL 330

Bridging neurocognitive aging and disease modification: targeting functional mechanisms of memory impairment

Gallagher M, Bakker A, Yassa MA, Stark CE.

Curr Alzheimer Res. 2010 May;7(3):197-9. doi: 10.2174/156720510791050867.

Low-dose divalproex in agitated patients with Alzheimer's disease

Dolder C, McKinsey J.

J Psychiatr Pract. 2010 Jan;16(1):63-7. doi: 10.1097/01.pra.0000367781.26507.86.

Anaesthetics and postoperative cognitive dysfunction: a pathological mechanism mimicking Alzheimer's disease

Fodale V, Santamaria LB, Schifilliti D, Mandal PK.

Anaesthesia. 2010 Apr;65(4):388-95. doi: 10.1111/j.1365-2044.2010.06244.x. Epub 2010 Feb 5.

Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations

Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R.

J Alzheimers Dis. 2010;20(1):301-11. doi: 10.3233/JAD-2010-1362.

Predictive factors of hospitalizations in Alzheimer's disease: a two-year prospective study in 686 patients of the REAL.FR study

Voisin T, Andrieu S, Cantet C, Vellas B; REAL.FR Group.

J Nutr Health Aging. 2010 Apr;14(4):288-91. doi: 10.1007/s12603-010-0063-4.

Is risk of Alzheimer disease a reason to use dietary supplements?

Dwyer J, Donoghue MD.

Am J Clin Nutr. 2010 May;91(5):1155-6. doi: 10.3945/ajcn.2010.29498. Epub 2010 Mar 24.

[Alzheimer's disease]

Jedidi H, Jedidi Z, Salmon E.

Rev Med Liege. 2010 Mar;65(3):163-8.

Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide

Viña J, Lloret A.

J Alzheimers Dis. 2010;20 Suppl 2:S527-33. doi: 10.3233/JAD-2010-100501.

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30.

Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice

Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z.

Anesthesiology. 2010 Jun;112(6):1404-16. doi: 10.1097/ALN.0b013e3181d94de1.

The arsenic exposure hypothesis for Alzheimer disease

Gong G, OʼBryant SE.

Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):311-6. doi: 10.1097/WAD.0b013e3181d71bc7.

Hormonal influences on cognition and risk for Alzheimer's disease

Janicki SC, Schupf N.

Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66. doi: 10.1007/s11910-010-0122-6.

Clinical practice. Early Alzheimer's disease

Mayeux R.

N Engl J Med. 2010 Jun 10;362(23):2194-201. doi: 10.1056/NEJMcp0910236.

Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome

De Simone R, Puig XS, Gélisse P, Crespel A, Genton P.

Seizure. 2010 Sep;19(7):383-9. doi: 10.1016/j.seizure.2010.04.008. Epub 2010 Jul 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias